Endovascular Stent Grafts Lead Global Aortic Aneurysm Device Market by Volume and Innovation

The global aortic aneurysm devices market size was valued at USD 3.46 billion in 2024 and is projected to register a CAGR of 9.3% from 2025 to 2034. This regional breakdown examines North America and Asia Pacific, highlighting how regulatory environments, technological advancements, trade policies, and demographic trends are shaping regional manufacturing trends, cross-border supply chains, and market penetration strategies. North America continues to dominate demand, while Asia Pacific emerges as the fastest-growing region, driven by healthcare infrastructure expansion and population aging.

North America accounted for approximately 46–51% of global market share in 2024, driven by high diagnosis rates, advanced endovascular treatment capacity, and strong reimbursement frameworks. Widespread adoption of EVAR and TEVAR devices reflects an entrenched preference for minimally invasive surgery among clinicians and payors. Regulatory clarity in the U.S. allows device developers to localize production and streamline approvals, supporting strategic market entry via established manufacturing bases and cross-border supply chains that leverage U.S.–Mexico–Canada trade accords. These mechanisms align with regional manufacturing trends and ensure procurement efficiency.

Asia Pacific recorded the highest regional CAGR at 11.35% and is projected to grow significantly through 2034. Aging in China and India, alongside investments in cardiovascular care centers, is driving demand for aortic aneurysm interventions. Trade facilitation agreements and equipment import tax relief are enabling cross-border supply chains, while medical device OEMs are establishing regional manufacturing and training hubs to support market penetration strategies in tier‑1 and tier‑2 cities. These developments mark early but clear steps toward regional manufacturing trends in APAC.

Read More @ https://www.polarismarketresearch.com/industry-analysis/aortic-aneurysm-devices-market

Drivers include an aging population requiring aneurysm repair, technological progress in stent grafts, and strong demand for minimally invasive treatment approaches. Restraints include cost pressures of advanced devices and limited procedural access in low-income regions. Opportunities exist in expanding device adoption through ambulatory surgery programs, local-manufactured components for APAC markets, and partnerships enabling telehealth-supported case management. Trends include consolidation of OEM portfolios, integration of stent graft design with imaging guidance, and supply chain realignment to reduce tariffs and improve delivery timelines.

Competitive landscape (top market holders):

  • Medtronic plc

  • W. L. Gore & Associates, Inc.

  • Cook Medical, Inc.

  • Endologix LLC

  • Terumo Corporation


These leading firms hold substantial share across regional markets, supported by innovation pipelines and strategic distribution networks. Their positioning aligns with cross-border supply chains and regional manufacturing trends designed to enhance clinical and economic access.

More Trending Latest Reports By Polaris Market Research:

Marketing Analytics Software Market

Digital Signature Market

Mice Model Market

Digital Health Market

Machine Risk Assessment Market

Fraise Mowers Market

Graphic Film Market

Data Diode Market

Gardening Equipment Market

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *